Nanoscale, 2015, Accepted Manuscript
DOI: 10.1039/C5NR01829C, Paper
DOI: 10.1039/C5NR01829C, Paper
Diogo Mata, Margarida Amaral, Antonio Jose Fernandes, Bruno Colaco, Adelina Gama, Maria Conceicao Paiva, Pedro Sousa Gomes, Rui F Silva, Maria Helena Fernandes
The risk-benefit balance for carbon nanotubes (CNTs) dictates their clinical fate. To take a step forward in this crossroad it is compulsory to modulate the CNT in vivo biocompatibility and...
The content of this RSS Feed (c) The Royal Society of Chemistry
The risk-benefit balance for carbon nanotubes (CNTs) dictates their clinical fate. To take a step forward in this crossroad it is compulsory to modulate the CNT in vivo biocompatibility and...
The content of this RSS Feed (c) The Royal Society of Chemistry
Click for full article
No comments:
Post a Comment